Sciatica Market, by Disease Type (Acute Sciatica, Chronic Sciatica, and Others), by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Oral Steroids, Anticonvulsant Agents, Tricyclic Antidepressants, Opioid Analgesics, and Others), by Route of Administrati

Sciatica Market, by Disease Type (Acute Sciatica, Chronic Sciatica, and Others), by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Oral Steroids, Anticonvulsant Agents, Tricyclic Antidepressants, Opioid Analgesics, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Sciatica refers to pain that radiates along the path of the sciatic nerve, which passes from lower back through hips to buttocks and down each leg. Typically, sciatica affects only one side of the body. This is often a chronic condition that is managed through the use of analgesics to control the pain and non-steroidal anti-inflammatory drugs (NSAIDS) to decrease inflammation. Sciatica is differentiated depending upon the severity of the pain faced by individuals such as acute sciatica, chronic sciatica, and others.
Acute sciatic is known as recent onset of pain in sciatic nerve for duration of four to eight weeks and pain can be self-managed by individuals through pain medications. In chronic sciatica, symptoms include persistent sciatic nerve pain, which lasts over eight weeks in individuals. There are two other types of sciatica which include alternating sciatica and bilateral sciatica. Alternating sciatica is a condition in which the sciatic nerve pain affects in both the legs alternately and thus may lead to degenerative problems in the sacroiliac joint. Bilateral sciatica is a condition in which the sciatic nerve pain occurs in both the legs together, this type of sciatic is very rare and may occur due to degenerative changes in the vertebrae and/or the disc at several spinal levels.
Market Dynamics
Increasing prevalence of sciatica is anticipated to drive the growth of global sciatica market over the forecast period. For instance, according to the article published in the Spine Health in December 2019, sciatica is common condition with a lifetime incidence varying from 10% to 40% of the population in the U.S.
Key features of the study:
This report provides in-depth analysis of the global sciatica market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sciatica market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sciatica market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sciatica market
Detailed Segmentation:
Global Sciatica Market, By Disease Type:
Acute Sciatica
Chronic Sciatica
Others
Global Sciatica Market, By Drug Class:
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
Global Sciatica Market, By Route of Administration:
Oral
Injectable
Global Sciatica Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sciatica Market, By Region:
North America
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Disease Type
Acute Sciatica
Chronic Sciatica
Others
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
Oral Steroids
Anticonvulsant Agents
Tricyclic Antidepressants
Opioid Analgesics
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Sorrento Therapeutics, Inc.
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma Ltd.
Zydus Cadila
Glenmark Pharmaceuticals Ltd.
Amneal Pharmaceuticals LLC
Jubilant Life Sciences Ltd.
Hikma Pharmaceuticals PLC.
Mylan N.V.
Horizon Therapeutics Plc.
Sun Pharmaceutical Industries Ltd.
Alkem Labs
SCILEX Pharmaceuticals, Inc.
Seikagaku Corporation
Kolon Life Science, Inc.
Teijin Limited
SpineThera, Inc.
“*” marked represents similar segmentation in other categories in the respective section.